Clinical case of compensatory nodular hyperplasia
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 1
Abstract
Despite the fact the benign liver neoplasms are relatively rare diseases, a clinician should be aware of such typical benign liver damage as focal nodular hyperplasia (FNH). The article presents a case report of a 36-year-old female who didn’t present with any typical complaints at the time of the examination. The results of computed tomography, puncture liver biopsy with histological and immunohistochemical studies confirmed the FNH diagnosis. The evidence-based recommendations of the European Association for the Study of the Liver (EASL) have been presented, that outlines data on the FNH diagnosis, methods of treatment, and follow-up of patients with this pathology. The FNH is considered to be a proliferative cell response to an aberrant dystrophic artery and can be associated with other conditions characterized by arterial damage, such as hereditary haemorrhagic telangiectasia or previously treated solid tumors in children. FNH is a polyclonal hepatocellular proliferation, considered as a hyperplastic reaction resulting from arterial malformation. Multiple FNHs can be observed in specific clinical context, especially in patients with underlying vascular liver diseases, such as Budd-Chiari syndrome, obliterative portal venopathy and congenital disorders, including hereditary haemorrhagic telangiectasia, portal vein agenesis. No sufficient data in favor or against the planned FNH surgical treatment available, but in the absence of symptoms and taking into account the rarity of complications, a conservative approach is recommended. The surgical treatment is only pursued in exceptional cases (for example, in case of the formation on a growing stalk or exophytic hyperplasia) and liver resection is the treatment of choice.
Authors and Affiliations
N. B. Gubergrits, O. О. Dyadyik, N. V. Bieliaieva, P. G. Fomenko, Yu. E. Chyrkov, S. O. Shpak
Keywords
Related Articles
- EP ID EP508333
- DOI 10.30978/MG-2019-1-59
- Views 117
- Downloads 0
Alcoholic liver fibrosis: the current state of a problem
The article presents data on pathogenetic mechanisms of development of fibrogenesis and alcoholic liver fibrosis. The factors of diseaseprogression and turnover have been outlined. The role of the drug Heparhizine as a c...
Gastrointestinal lesions in patients, administrated acetylsalicylic acid for cardiovascular pathology: the syndromic diagnosis and possible methods of correction
Objective — to determine the effects of acetylsalicylic acid (ASA) preparations on the development of gastrointestinal tract lesions and to assess their severity depending on the use of PPIs, with the help of GSRS questi...
Intestinal dysbiosis, obesity and metabolic syndrome: how to quit this tricky triangle?
The paper presents analysis of the data of worldwide literature, results of evidence-based experimental and clinical trials on the relationship between dietary habits and intestinal microbiota. The particular attention i...
The evaluation of specific changes and diagnostic informativeness of the cytokine profile in young patients with gastroesophageal reflux disease, occurring against the background of autoimmune inflammation
Objective — to determine the general trend of changes in the indicators of systemic inflammation — interleukin-1β and interleukin-18, in young patients with gastroesophageal reflux disease (GERD) and autoimmune thyroidit...
Non-invasive diagnosis of non-alcoholic fatty liver disease: the available opportunities we have today
Non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly common disease, it is currently diagnosed in more than a quarter of adult population worldwide, and its portion in the overweight patients with type 2...